Literature DB >> 19643089

Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation.

Vicent Casadó1, Carla Ferrada, Jordi Bonaventura, Eduard Gracia, Josefa Mallol, Enric I Canela, Carmen Lluís, Antoni Cortés, Rafael Franco.   

Abstract

Many G-protein-coupled receptors (GPCRs) are expressed on the plasma membrane as dimers. Since drug binding data are currently fitted using equations developed for monomeric receptors, the interpretation of the pharmacological data are equivocal in many cases. As reported here, GPCR dimer models account for changes in competition curve shape as a function of the radioligand concentration used, something that cannot be explained by monomeric receptor models. Macroscopic equilibrium dissociation constants for the agonist and homotropic cooperativity index reflecting the intramolecular communication within the dopamine D1 or adenosine A2A receptor homodimer as well as hybrid equilibrium dissociation constant, which reflects the antagonist/agonist modulation may be calculated by fitting binding data from antagonist/agonist competition experiments to equations developed from dimer receptor models. Comparing fitting the data by assuming a classical monomeric receptor model or a dimer model, it is shown that dimer receptor models provide more clues useful in drug discovery than monomer-based models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643089     DOI: 10.1016/j.bcp.2009.07.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

Review 1.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

3.  Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.

Authors:  Daniel Farré; Ana Muñoz; Estefanía Moreno; Irene Reyes-Resina; Júlia Canet-Pons; Iria G Dopeso-Reyes; Alberto J Rico; Carme Lluís; Josefa Mallol; Gemma Navarro; Enric I Canela; Antonio Cortés; José L Labandeira-García; Vicent Casadó; José L Lanciego; Rafael Franco
Journal:  Mol Neurobiol       Date:  2014-10-26       Impact factor: 5.590

4.  Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.

Authors:  Verònica Casadó-Anguera; Estefanía Moreno; Josefa Mallol; Sergi Ferré; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Pharmacol Res       Date:  2018-11-22       Impact factor: 7.658

5.  α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Authors:  Marta Sánchez-Soto; Verònica Casadó-Anguera; Hideaki Yano; Brian Joseph Bender; Ning-Sheng Cai; Estefanía Moreno; Enric I Canela; Antoni Cortés; Jens Meiler; Vicent Casadó; Sergi Ferré
Journal:  Mol Neurobiol       Date:  2018-03-18       Impact factor: 5.590

6.  Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum.

Authors:  Rafael Franco; Verònica Casadó-Anguera; Ana Muñoz; Milos Petrovic; Gemma Navarro; Estefanía Moreno; José Luis Lanciego; José Luis Labandeira-García; Antoni Cortés; Vicent Casadó
Journal:  Mol Neurobiol       Date:  2015-10-09       Impact factor: 5.590

Review 7.  GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers?

Authors:  Vicent Casadó; Antoni Cortés; Josefa Mallol; Kamil Pérez-Capote; Sergi Ferré; Carmen Lluis; Rafael Franco; Enric I Canela
Journal:  Pharmacol Ther       Date:  2009-08-05       Impact factor: 13.400

8.  Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.

Authors:  Sergi Ferré; César Quiroz; Xavier Guitart; William Rea; Arta Seyedian; Estefanía Moreno; Verònica Casadó-Anguera; Manuel Díaz-Ríos; Vicent Casadó; Stefan Clemens; Richard P Allen; Christopher J Earley; Diego García-Borreguero
Journal:  Front Neurosci       Date:  2018-01-08       Impact factor: 4.677

9.  Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.

Authors:  Daniel Pulido; Verònica Casadó-Anguera; Laura Pérez-Benito; Estefanía Moreno; Arnau Cordomí; Laura López; Antoni Cortés; Sergi Ferré; Leonardo Pardo; Vicent Casadó; Miriam Royo
Journal:  J Med Chem       Date:  2018-10-11       Impact factor: 8.039

Review 10.  Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization.

Authors:  Rafael Franco; Eva Martínez-Pinilla; José L Lanciego; Gemma Navarro
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.